☰

Robert Allen Owens

Affiliations: 
Pharmacology/Toxicology Virginia Commonwealth University, Richmond, VA, United States 
Google:
"Robert Owens"
Mean distance: 15.53 (cluster 19)
 		SNBCP
Cross-listing: Chemistry Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Aron H. Lichtman grad student 2012- VCU
William R. Roush post-doc 2003-2005 Scripps Research Institute Florida (Chemistry Tree)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Owens RA, Mustafa MA, Ignatowska-Jankowska BM, et al. (2017) Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Neuropharmacology
Owens RA, Ignatowska-Jankowska BM, Mustafa M, et al. (2016) Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice. The Journal of Pharmacology and Experimental Therapeutics
Wiley JL, Owens RA, Lichtman AH. (2016) Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids. Current Topics in Behavioral Neurosciences
Wiebelhaus JM, Grim TW, Owens RA, et al. (2015) Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice. The Journal of Pharmacology and Experimental Therapeutics. 352: 195-207
Owens R, Beardsley P, cravatt B, et al. (2015) Dual blockade of endocannabinoid hydrolyzing enzymes reveal a CB 1 receptor-mediated interoceptive stimulus Drug and Alcohol Dependence. 156: e168
Ramesh D, Gamage TF, Vanuytsel T, et al. (2013) Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1039-49
Ramesh D, Ross GR, Schlosburg JE, et al. (2011) Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice. The Journal of Pharmacology and Experimental Therapeutics. 339: 173-85
Gunn JM, Owens RA, Liu WS, et al. (1981) Biological activity of aspartic proteinase inhibitors related to pepstatin. Acta Biologica Et Medica Germanica. 40: 1547-53
See more...